Who Owns Indaptus Therapeutics Inc (INDP)? 13F Institutional Holders (Q2 2026)

INDP ranks #10304 out of 37701 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

INDP is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

9 institutions disclose a position in INDP, but none treat it as a major bet — even Hrt Financial LP, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

INDP is up 0.3% today, and institutions have been net buyers of $1.1M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

INDP reported a net loss of $20.8M in its latest fiscal year.

• Not yet profitable — net loss of $20.8M in the latest fiscal year
• Net income declined year over year, from -$15.0M to -$20.8M
• Operating cash flow was negative, using $14.8M in cash
• Current ratio of 1.51x — enough short-term assets to cover short-term liabilities
• Liabilities run x equity — a highly leveraged balance sheet worth noting